Summary of project PR002069

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR002069. The data can be accessed directly via it's Project DOI: 10.21228/M85R82 This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

Project ID: PR002069
Project DOI:doi: 10.21228/M85R82
Project Title:Control Of Major Bleeding After Trauma (COMBAT) Clinical Research Study Metabolomics
Project Summary:Denver Health has conducted the Control of Major Bleeding After Trauma (COMBAT) clinical research study, which aimed to improve trauma care for all patients (https://www.denverhealth.org/services/trauma/for-professionals-2/research-publications/combattrial). The study began in April 2014 and concluded in March of 2017. In collaboration with the University of Colorado Anschutz Medical Campus, longitudinal plasma samples collected from the COMBAT trial were analyzed by MS-based metabolomics and proteomics (data available on ProteomeXchange).
Institute:University of Colorado Anschutz Medical Campus
Department:Biochemistry and Molecular Genetics
Laboratory:The Hansen and D'Alessandro Labs
Last Name:LaCroix
First Name:Ian
Address:RC1-S L18-9403G E 17th Ave. Aurora, CO 80045
Email:ian.lacroix@cuanschutz.edu
Phone:(303) 724-0096
Publications:doi:10.1001/jamasurg.2019.5085, DOI: 10.1016/S0140-6736(18)31553-8, DOI: 10.1097/SHK.0000000000000376

Summary of all studies in project PR002069

Study IDStudy TitleSpeciesInstituteAnalysis
(* : Contains Untargted data)		 Release
Date		VersionSamplesDownload
(* : Contains raw data)
ST003327 Control Of Major Bleeding After Trauma (COMBAT) Clinical Research Trial Metabolomics Homo sapiens University of Colorado Anschutz Medical Campus MS 2024-08-08 1 726 Not available
  logo